window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • CDMOs & Manufacturing,Global health,Regulatory Affairs,Research & Development,Supply Chain & Logistics,Technology and platforms

    SGD Pharma targets 42% emissions cut by 2030 in new sustainability report

    Company aligns with CSRD and reports top 1% EcoVadis ranking [...]

    July 28, 2025
  • Drug Development,Global health,Precision medicine,Rare Diseases,Research & Development,Technology and platforms

    First Arab human pangenome reveals millions of novel variants using long-read sequencing

    Study powered by PacBio HiFi sequencing offers new insight into [...]

    July 28, 2025
  • CDMOs & Manufacturing,Global health,Regulatory Affairs,Research & Development,Supply Chain & Logistics,Technology and platforms

    SGD Pharma targets 42% emissions cut as it tops global CSR rankings

    New sustainability report outlines performance across climate, equality, ethics, and [...]

    July 28, 2025
  • Artificial Intelligence,Clinical Trials,Patient Centricity,Precision medicine,Technology and platforms

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    July 28, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Global health,Movers & Shakers,Supply Chain & Logistics,Technology and platforms

    Colorcon expands global supply network with new pharmaceutical film coating facility in Malaysia

    Colorcon has officially opened a new pharmaceutical film coating manufacturing [...]

    July 25, 2025
  • Clinical Development,Oncology,Partnerships & Funding,Regulatory Affairs,Research & Development,Technology and platforms

    Start and Advarra unite to accelerate early-phase oncology trials with integrated technology

    The START Center for Cancer Research has formed a strategic [...]

    July 25, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Partnerships & Funding,Research & Development,Technology and platforms

    AI-powered bioreactor project aims to transform biologics manufacturing

    A Canada–UK collaboration is developing an AI-driven bioreactor platform designed [...]

    July 25, 2025
  • Global health,Partnerships & Funding,Precision medicine,Rare Diseases,Research & Development,Technology and platforms

    PacBio brings isoform-level insights to 1000 Genomes Project with HiFi sequencing

    PacBio is contributing long-read transcriptomic data to the 1000 Genomes [...]

    July 25, 2025
  • Artificial Intelligence,Drug Development,Oncology,Partnerships & Funding,Technology and platforms

    Scientist.com expands AI-powered Tumor Model Finder with XenoSTART cancer models

    Scientist.com has expanded its AI-powered Tumor Model Finder through a [...]

    July 24, 2025
  • Biologics & Biosimilars,Drug Development,European biotech,Partnerships & Funding,Precision medicine,Technology and platforms

    Kling Bio and Sanofi collaborate to accelerate discovery of next-generation antiviral antibodies

    Biotech company Kling Bio has announced a new collaboration with [...]

    July 24, 2025
Previous171819Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Chiesi gains CHMP backing for lomitapide in children with rare cholesterol disorder
    Categories: Cardiovascular diseases, Clinical Trials, Drug approval, Rare Diseases
  • Strategies to extend ketamine antidepressant effects identified in new study
    Categories: Central Nervous System, Mental health, Neurosciences, Research & Development
  • Bullfrog AI signs commercial agreement with top 5 global pharma company to identify novel target in major depressive disorder
    Categories: Artificial Intelligence, Digital Health, Mental health, Neurosciences, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top